Tamara Y Milder (T Y Milder)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Emergency Department

Disease Activity

Top Venues

Diabetes, obesity & metabolism

British journal of clinical pharmacology

Internal medicine journal

This page only lists publications with an associated author ORCID identifier.

Publications

Tamara Y Milder, Jialing Lin, Sallie-Anne Pearson, Jerry R Greenfield, Richard Osborne Day, Sophie Lena Stocker, Brendon L Neuen, Michael O Falster, Juliana de Oliveira Costa
Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022. British journal of clinical pharmacology (2024)
Juliana de Oliveira Costa, Jialing Lin, Tamara Y Milder, Jerry R Greenfield, Richard Osborne Day, Sophie Lena Stocker, Brendon L Neuen, Alys Havard, Sallie-Anne Pearson, Michael O Falster
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia. Diabetes, obesity & metabolism (2024)
Juliana de Oliveira Costa, Jialing Lin, Tamara Y Milder, Jerry R Greenfield, Richard Osborne Day, Sophie Lena Stocker, Brendon L Neuen, Alys Havard, Sallie-Anne Pearson, Michael O Falster
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia. Diabetes, obesity & metabolism 26 (7) (2024)
Juliana de Oliveira Costa, Jialing Lin, Tamara Y Milder, Jerry R Greenfield, Richard Osborne Day, Sophie Lena Stocker, Brendon L Neuen, Alys Havard, Sallie-Anne Pearson, Michael O Falster
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia. Diabetes, obesity & metabolism 26 (7) (2024)
Tamara Y Milder, Sophie Lena Stocker, Melissa Therese Baysari, Richard Osborne Day, Jerry R Greenfield
'We are somehow fixated on this being a diabetes drug': a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiation. Internal medicine journal (2023)
Tamara Y Milder, David A Milder, Jerry R Greenfield, Richard O Day
Sodium-Glucose Cotransporter 2 Inhibitor-Associated "Ketoacidosis" Versus "Diabetic Ketoacidosis": The Importance of Accurate Terminology. Drug safety (2023)
Tamara Y Milder, Jerry R Greenfield, D A Milder
Peri-procedural ketoacidosis risk with sodium-glucose cotransporter 2 inhibitor use in people without diabetes. Anaesthesia (2023)